ZA991664B - 3,6-ketal and enol ether macrolide antibiotics. - Google Patents
3,6-ketal and enol ether macrolide antibiotics.Info
- Publication number
- ZA991664B ZA991664B ZA9901664A ZA991664A ZA991664B ZA 991664 B ZA991664 B ZA 991664B ZA 9901664 A ZA9901664 A ZA 9901664A ZA 991664 A ZA991664 A ZA 991664A ZA 991664 B ZA991664 B ZA 991664B
- Authority
- ZA
- South Africa
- Prior art keywords
- ketal
- enol ether
- macrolide antibiotics
- macrolide
- antibiotics
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7663098P | 1998-03-03 | 1998-03-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA991664B true ZA991664B (en) | 2000-10-12 |
Family
ID=22133253
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA9901664A ZA991664B (en) | 1998-03-03 | 1999-03-02 | 3,6-ketal and enol ether macrolide antibiotics. |
Country Status (17)
Country | Link |
---|---|
US (1) | US6043226A (ja) |
EP (1) | EP0941998B1 (ja) |
JP (1) | JP3666788B2 (ja) |
CN (1) | CN1244532A (ja) |
AR (1) | AR016715A1 (ja) |
AT (1) | ATE275151T1 (ja) |
AU (1) | AU741435B2 (ja) |
BR (1) | BR9900856A (ja) |
CA (1) | CA2263203C (ja) |
DE (1) | DE69919769T2 (ja) |
DK (1) | DK0941998T3 (ja) |
ES (1) | ES2226282T3 (ja) |
HU (1) | HUP9900492A3 (ja) |
NO (1) | NO312366B1 (ja) |
NZ (1) | NZ334442A (ja) |
PT (1) | PT941998E (ja) |
ZA (1) | ZA991664B (ja) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AP1060A (en) * | 1998-01-02 | 2002-04-23 | Pfizer Prod Inc | Novel erythromycin derivatives. |
AP9801420A0 (en) * | 1998-01-02 | 1998-12-31 | Pfizer Prod Inc | Novel macrolides. |
ID28286A (id) | 1998-11-03 | 2001-05-10 | Pfizer Prod Inc | Antibiotik-antibiotik makrolida baru |
US6514944B2 (en) | 1999-04-16 | 2003-02-04 | Kosan Biosciences, Inc. | Macrolide antiinfective agents |
US6590083B1 (en) * | 1999-04-16 | 2003-07-08 | Ortho-Mcneil Pharmaceutical, Inc. | Ketolide antibacterials |
US6939861B2 (en) | 1999-04-16 | 2005-09-06 | Kosan Biosciences, Inc. | Amido macrolides |
US6451768B1 (en) | 1999-04-16 | 2002-09-17 | Kosan Biosciences, Inc. | Macrolide antiinfective agents |
ATE340183T1 (de) | 1999-04-16 | 2006-10-15 | Kosan Biosciences Inc | Antiinfektiöse makrolidderivate |
CA2373117C (en) * | 1999-05-24 | 2006-02-28 | Pfizer Products Inc. | 13-methyl-erythromycin derivatives |
EP1146051A3 (en) * | 2000-04-10 | 2001-10-31 | Pfizer Products Inc. | Erythromycin A derivatives |
CA2428158C (en) * | 2000-11-07 | 2010-06-29 | Morphotek, Inc. | Methods for isolating novel antimicrobial agents from hypermutable mammalian cells |
US8063021B2 (en) * | 2002-01-17 | 2011-11-22 | Kosan Biosciences Incorporated | Ketolide anti-infective compounds |
ITMI20021726A1 (it) | 2002-08-01 | 2004-02-02 | Zambon Spa | Macrolidi ad attivita' antiinfiammatoria. |
ITMI20022292A1 (it) * | 2002-10-29 | 2004-04-30 | Zambon Spa | 9a-azalidi ad attivita' antiinfiammatoria. |
US20060141470A1 (en) * | 2003-02-14 | 2006-06-29 | Kalayoglu Murat V | Chlamydia pneumoniae associated chronic intraocular disorders and treatment thereof |
BRPI0519135A2 (pt) * | 2004-12-21 | 2008-12-23 | Pfizer Prod Inc | macrolÍdeos |
US7517859B2 (en) * | 2005-05-04 | 2009-04-14 | Enanta Pharmaceuticals, Inc. | Spirocyclic bicyclolides |
EP2203435B1 (en) * | 2007-09-17 | 2018-07-18 | Enanta Pharmaceuticals, Inc. | 6, 11-bridged biaryl macrolides |
WO2018193116A1 (en) * | 2017-04-20 | 2018-10-25 | Novintum Biotechnology Gmbh | Azithromycin derivatives containing a phosphonium ion as anticancer agents |
WO2018193111A1 (en) * | 2017-04-20 | 2018-10-25 | Novintum Biotechnology Gmbh | Azithromycin derivatives containing a phosphonium ion as anticancer agents |
GB201706299D0 (en) * | 2017-04-20 | 2017-06-07 | Novintum Biotechnology Gmbh | Compounds |
WO2018193126A1 (en) * | 2017-04-20 | 2018-10-25 | Novintum Biotechnology Gmbh | Azithromycin derivatives containing a phosphonium ion as antibacterial agents |
US11560395B2 (en) | 2017-04-20 | 2023-01-24 | Rising Tide Foundation | Azithromycin derivatives containing a phosphonium ion as anticancer agents |
JP2020517749A (ja) * | 2017-04-20 | 2020-06-18 | ライジング タイド ファウンデーション | 抗がん剤としてホスホニウムイオンを含むアジスロマイシン誘導体 |
WO2018195434A1 (en) | 2017-04-21 | 2018-10-25 | Lisanti Michael P | Vitamin c and doxycycline: a synthetic lethal combination therapy for eradicating cancer stem cells (cscs) |
US11229657B2 (en) | 2017-04-21 | 2022-01-25 | Lunella Biotech, Inc. | Targeting hypoxic cancer stem cells (CSCs) with doxycycline: implications for improving anti-angiogenic therapy |
RU2019142102A (ru) | 2017-05-19 | 2021-06-21 | Лунелла Байотек, Инк. | Антимитосцины: направленные ингибиторы митохондриального биогенеза для эрадикации злокачественных стволовых клеток |
US12006553B2 (en) | 2017-05-19 | 2024-06-11 | Lunella Biotech, Inc. | Companion diagnostics for mitochondrial inhibitors |
CU20190106A7 (es) | 2017-06-26 | 2020-11-30 | Lunella Biotech Inc | Mitocetoscinas: agentes terapéuticos basados en mitocondrias que fijan como objetivo el metabolismo de cetonas en células cancerosas |
GB201817083D0 (en) * | 2018-10-19 | 2018-12-05 | Novintum Biotechnology Gmbh | Compounds |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8721165D0 (en) * | 1987-09-09 | 1987-10-14 | Beecham Group Plc | Chemical compounds |
EP0344106A3 (de) * | 1988-05-24 | 1990-01-31 | Ciba-Geigy Ag | Blaue Dispersionsfarbstoffe und Mischungen blauer Dispersionsfarbstoffe |
US5302705A (en) * | 1989-10-07 | 1994-04-12 | Taisho Pharmaceutical Co., Ltd. | 6-O-methylerythromycin a oxime derivatives |
KR960700258A (ko) * | 1993-01-26 | 1996-01-19 | 우에하라 아키라 | 5-0-데소사미닐에리쓰로노라이드 유도체 |
WO1997042204A1 (en) * | 1996-05-07 | 1997-11-13 | Abbott Laboratories | 6-o-substituted erythromycins and method for making them |
-
1999
- 1999-02-23 DK DK99301325T patent/DK0941998T3/da active
- 1999-02-23 EP EP99301325A patent/EP0941998B1/en not_active Expired - Lifetime
- 1999-02-23 PT PT99301325T patent/PT941998E/pt unknown
- 1999-02-23 AT AT99301325T patent/ATE275151T1/de not_active IP Right Cessation
- 1999-02-23 ES ES99301325T patent/ES2226282T3/es not_active Expired - Lifetime
- 1999-02-23 DE DE69919769T patent/DE69919769T2/de not_active Expired - Fee Related
- 1999-02-25 US US09/257,709 patent/US6043226A/en not_active Expired - Fee Related
- 1999-03-01 CA CA002263203A patent/CA2263203C/en not_active Expired - Fee Related
- 1999-03-01 AR ARP990100858A patent/AR016715A1/es unknown
- 1999-03-02 ZA ZA9901664A patent/ZA991664B/xx unknown
- 1999-03-02 NZ NZ334442A patent/NZ334442A/xx unknown
- 1999-03-02 JP JP05371599A patent/JP3666788B2/ja not_active Expired - Fee Related
- 1999-03-02 NO NO19991012A patent/NO312366B1/no not_active IP Right Cessation
- 1999-03-02 HU HU9900492A patent/HUP9900492A3/hu unknown
- 1999-03-03 AU AU18562/99A patent/AU741435B2/en not_active Ceased
- 1999-03-03 BR BR9900856-4A patent/BR9900856A/pt not_active IP Right Cessation
- 1999-03-03 CN CN99105681A patent/CN1244532A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
EP0941998A2 (en) | 1999-09-15 |
DK0941998T3 (da) | 2004-09-20 |
NO991012L (no) | 1999-09-06 |
BR9900856A (pt) | 2000-04-25 |
JP3666788B2 (ja) | 2005-06-29 |
CA2263203C (en) | 2002-09-03 |
AU741435B2 (en) | 2001-11-29 |
CA2263203A1 (en) | 1999-09-03 |
PT941998E (pt) | 2004-12-31 |
CN1244532A (zh) | 2000-02-16 |
ES2226282T3 (es) | 2005-03-16 |
US6043226A (en) | 2000-03-28 |
ATE275151T1 (de) | 2004-09-15 |
NO991012D0 (no) | 1999-03-02 |
NO312366B1 (no) | 2002-04-29 |
AR016715A1 (es) | 2001-07-25 |
DE69919769T2 (de) | 2005-01-27 |
JPH11315093A (ja) | 1999-11-16 |
EP0941998B1 (en) | 2004-09-01 |
NZ334442A (en) | 2000-03-27 |
HU9900492D0 (en) | 1999-04-28 |
HUP9900492A2 (hu) | 1999-09-28 |
EP0941998A3 (en) | 1999-10-06 |
DE69919769D1 (de) | 2004-10-07 |
AU1856299A (en) | 1999-09-16 |
HUP9900492A3 (en) | 2001-08-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA991664B (en) | 3,6-ketal and enol ether macrolide antibiotics. | |
ZA9811939B (en) | Novel macrolides. | |
ZA996185B (en) | Sulfanylsilanes. | |
ZA200005136B (en) | Dihydropyrimides. | |
ZA991951B (en) | Compound and its use. | |
ZA973241B (en) | Surfactant manufacture. | |
HK1036101A1 (en) | Refrigerator. | |
ZA9710429B (en) | Broad-spectrumδ-endotoxins. | |
ZA9811940B (en) | Novel erythromycin derivatives. | |
ZA99452B (en) | Antibodies against human IL-12. | |
ZA200103289B (en) | Novel macrolide antibiotics. | |
ZA985018B (en) | 9-oxime erythromycin derivatives. | |
ZA975742B (en) | Modified oligonucleotides. | |
ZA992443B (en) | Hydroxy-methyl-hexanones. | |
ZA9711461B (en) | Lipophilic oligosaccharide antibiotic compositions. | |
AU3830799A (en) | Molecular rod and uses | |
ZA993123B (en) | Trisresorcinyltriazines. | |
ZA995325B (en) | Methylcyclotetradec-5-en-1-ones. | |
ZA978086B (en) | New pyranoside derivatives. | |
ZA983902B (en) | Erythromycin derivatives. | |
AU2964899A (en) | 2,4-dioxo-5-arylidenimino-1,3-pyrimidines | |
AU1974900A (en) | Macrolide intermediates in the preparation of clarithromycin | |
ZA99496B (en) | Extrudate shrinkage control and reduction. | |
ZA97195B (en) | Wireless messaging system. | |
ZA992904B (en) | Parbaked bread. |